At Brii Biosciences, scientific innovation and improved patient health are at the core of what we do. We believe there has never been a better time to dramatically change the way healthcare is developed and delivered in China. Science, however, has no borders, and our R&D engine is poised to discover and develop innovative medicines that have the potential to improve the health of patients around the world.

We are committed to advancing solutions for some of the most common illnesses worldwide where current treatments are insufficient or nonexistent. We seek to redefine therapeutic areas through the application of big, bold ideas that can make a significant and singular contribution to science and health. >PIPELINE

Dedication to China

The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. These innovations, however, have not always reached the patients in China who need them. We will apply our R&D and commercial expertise to help Chinese patients gain earlier access to more affordable, innovative medicines.


Delivering a Global Impact

Even as we focus intently on the needs of patients in China, we are pursuing opportunities to improve the health of patients around the globe by marrying our research-intensive company with the capabilities and talents of multinational partners.